SCHEMBL6175823

SCHEMBL6175823

Cc1cc(CC2(C)NC(=O)N(c3ccc(SC(F)(F)F)cc3)C2=O)c2ccccc2n1

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 12/20 0.39
ADAM17 P78536 4/20 0.38
MMP13 P45452 1/20 0.38
AR P10275 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175753 0.91 IGF1R (0.42) IGF1RAR
SCHEMBL6171604 0.90 IGF1R (0.42) IGF1RAR
SCHEMBL6172631 0.90 IGF1R (0.42) IGF1RAR
SCHEMBL6175012 0.89 IGF1R (0.45) IGF1RAR
SCHEMBL6176994 0.85 KDM4E (0.40) IGF1R
SCHEMBL6173427 0.85 IGF1R (0.45) IGF1RAR
SCHEMBL6175028 0.85 IGF1R (0.45) IGF1RAR
Trifluoroacetic Acid SCHEMBL17558379 0.83 IGF1R (0.42) IGF1RAR
SCHEMBL6175137 0.80 IGF1R (0.38) IGF1RAR
SCHEMBL2942409 0.79 IGF1R (0.59) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed